2006
DOI: 10.1089/ten.2006.12.3341
|View full text |Cite
|
Sign up to set email alerts
|

Translation from Research to Applications

Abstract: The article summarizes the collective views expressed at the fourth session of the workshop Tissue Engineering-the Next Generation, which was devoted to the translation of results of tissue engineering research into applications. Ernst Hunziker described the paradigm of a dual translational approach, and argued that tissue engineering should be guided by the dimensions and physiological setting of the bodily compartment to be repaired. Myron Spector discussed collagen-glycosaminoglycan (GAG) scaffolds for musc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
64
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 71 publications
(67 citation statements)
references
References 123 publications
0
64
0
Order By: Relevance
“…A 510-K pathway for a tissue engineering scaffold may cost $ 5-10 million, while a PMA pathway may cost well over $ 50 million. [76] In summary, issues beyond initial scaffold design, material synthesis, and manufacturing research are often more than 50% of the work that goes into making a scaffold a clinical product. Many technologies reach the spin-off stage but then face either significant regulatory issues, significant manufacturing scaling issues, or lack of surgical acceptance.…”
Section: Scaffold Design and Manufacturing : Towards Clinical Applicamentioning
confidence: 99%
“…A 510-K pathway for a tissue engineering scaffold may cost $ 5-10 million, while a PMA pathway may cost well over $ 50 million. [76] In summary, issues beyond initial scaffold design, material synthesis, and manufacturing research are often more than 50% of the work that goes into making a scaffold a clinical product. Many technologies reach the spin-off stage but then face either significant regulatory issues, significant manufacturing scaling issues, or lack of surgical acceptance.…”
Section: Scaffold Design and Manufacturing : Towards Clinical Applicamentioning
confidence: 99%
“…8,32 Our experiments showed superior properties in dynamicloaded constructs, compared with static-loaded ones. Similarly, using an in vivo model, Liu et al illustrated gains in tensile strength following dynamic-loading.…”
mentioning
confidence: 69%
“…8 For the optimization of construct biomechanics in this study, the latter group of devices was utilized.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations